Notice on Convening the 5th Extraordinary General Meeting in 2026
Securities code: 603139 Securities abbreviation: Kanghui Shares Announcement number: 2026-072 Shaanxi Kanghui Pharmaceutical Co., Ltd.
Notice on convening the fifth extraordinary shareholders' meeting in 2026
The company's board of directors and all directors guarantee that the contents of this announcement do not contain any false records, misleading statements or major omissions, and assume legal responsibility for the authenticity, accuracy and completeness of its contents.
Important content reminder:
Date of shareholders’ meeting: September 7, 2026
The online voting system adopted for this shareholders’ meeting: Shanghai Stock Exchange Shareholders’ Meeting Online Voting System
1. Basic information on convening the meeting
(1) Type and session of shareholders’ meeting
The fifth extraordinary shareholders' meeting in 2026
(2) Convener of shareholders’ meeting: Board of Directors
(3) Voting method: The voting method used in this shareholders’ meeting is a combination of on-site voting and online voting.
way
(4) Date, time and place of on-site meeting
Date and time of the meeting: 14:30 on September 7, 2026
Venue: Conference Room on the 10th floor of Shiji Technology Building, No. 17 Chaoqian Road, Changping District, Beijing
(5) Online voting system, start and end dates and voting time.
Online voting system: Shanghai Stock Exchange Shareholders Meeting online voting system
Online voting starts and ends on September 7, 2026
Until September 7, 2026
Using the Shanghai Stock Exchange's online voting system, the voting time through the trading system voting platform is the trading time period on the day the shareholders' meeting is held, that is, 9:15-9:25, 9:30-11:30, 13:00-15:00; the voting time through the Internet voting platform is 9:15-15:00 on the day the shareholders' meeting is held.
(6) Voting procedures for margin trading, securities lending, refinancing, agreed repurchase business accounts and Shanghai-Hong Kong Stock Connect investors
Voting involving accounts related to margin financing and securities lending, refinancing business, agreed repurchase business, and Shanghai-Hong Kong Stock Connect investors shall be conducted in accordance with the "Shanghai Stock Exchange Self-Discipline Supervision Guidelines for Listed Companies No. 1 - Standardized Operations"
"Work" and other relevant regulations shall be implemented.
(7) Involving public solicitation of shareholder voting rights
None
2. Matters to be considered at the meeting
The resolutions to be reviewed and the types of voting shareholders at this shareholders’ meeting
Voting shareholder type serial number Proposal name
Non-cumulative voting resolution for A-share shareholders
1 Proposal on the transfer of 51% shares of Chunsheng Pharmaceutical and related transactions √
Regarding the transfer of the equity of Chunsheng Pharmaceutical to passively form related guarantees and take over
2 √
Proposal on counter-guarantee provided by related parties
3 Proposal on increasing registered capital and amending the Articles of Association √
- The time and disclosure media of each proposal
The relevant proposals were reviewed and approved at the 15th meeting of the company's sixth board of directors on August 21, 2026. Relevant announcements have been disclosed on the Shanghai Stock Exchange website (http://www.sse.com.cn) and China Securities Journal, Shanghai Securities News, Securities Times and Securities Daily. The company will upload the meeting materials to the website of the Shanghai Stock Exchange for disclosure before the shareholders' meeting.
Special resolutions: 3
Proposals to count votes separately for small and medium investors: 1, 2, 3
Proposals involving related shareholders’ avoidance of voting: 1, 2
Names of related shareholders who should avoid voting: Jiaxing Yuehe Zhichuang Technology Partnership (Limited Partnership), Shaanxi Kanghui Holdings Co., Ltd., Wang Yanling, Wang Xiuying, Yang Jin and those who work in the company and also serve as directors, supervisors and senior executives of Chunsheng Pharmaceutical
- Proposals involving preference shareholders’ participation in voting: None
3. Things to note when voting at the shareholders’ meeting
(1) The shareholders of the Company who exercise their voting rights through the online voting system of the Shanghai Stock Exchange’s shareholders’ meeting can either log in to the trading system voting platform (through the trading terminal of the securities company designated for trading) to vote, or log in to the Internet voting platform (website: vote.sseinfo.com) to vote. When logging into the Internet voting platform to vote for the first time, investors need to complete shareholder identity authentication. For specific operations please
See the Internet voting platform website description.
(2) If the same voting right is voted repeatedly through on-site, the Exchange’s online voting platform or other methods,
The results of the first vote shall prevail.
(3) For a shareholder holding multiple shareholder accounts, the number of exercisable voting rights is the total number of common shares of the same category and preference shares of the same variety held by all shareholder accounts under his or her name.
Shareholders holding multiple shareholder accounts who participate in online voting at the shareholders' meeting through the Exchange's online voting system can participate through any of their shareholder accounts. After voting, all shareholder accounts are deemed to be in the same category.
Both ordinary shares and preferred shares of the same type have voted with the same opinion.
If a shareholder holding multiple shareholder accounts votes repeatedly through multiple shareholder accounts, the voting opinions of the same class of ordinary shares and the same type of preferred stocks under all shareholder accounts shall be based on the first voting results of each class and type of stocks respectively.
(4) Shareholders must vote on all proposals before they can be submitted.
4. Participants at the meeting
(1) Shareholders of the company who are registered in the Shanghai Branch of China Securities Depository and Clearing Co., Ltd. at the market close in the afternoon on the equity registration day have the right to attend the shareholders’ meeting (see the table below for details), and may entrust a proxy in writing to attend the meeting and participate in voting. The agent does not have to be a shareholder of the company.
Share class Stock code Stock abbreviation Equity registration date
A shares 603139 Kanghui Shares 2026/9/2
(2) Directors and senior managers of the company.
(3) Lawyers hired by the company.
(4) Other personnel
5. Meeting registration method
For legal person shareholders, the legal representative shall carry out the registration procedures with the original and copy of his or her ID card, a copy of the legal person's business license (with the official seal of the legal person), and the shareholder account card;
Natural person shareholders must present the original and copy of their ID card and shareholder account card to complete the registration procedures;
The entrusted agent must hold the original and photocopy of the identity cards of both parties, a power of attorney (the power of attorney for the legal representative of the legal person shareholder must be stamped with the official seal of the legal person), and the client's shareholder account card to complete the registration procedures;
Shareholders from other places can register by fax;
Shareholders who choose to vote online can directly participate in voting at the shareholders’ meeting through the Shanghai Stock Exchange trading system.
(2) Registration time
September 4, 2026 9:30-11:30 am, 14:00-17:00 pm
(3) Registration location and contact information
Address: No. 36 Yanzhi Road, Qindu District, Xianyang City
Tel: 029-33347561
Fax: 029-33347561
Email: [email protected]
Contact: Kanghui Securities Affairs Department
6. Other matters
Shareholders and representatives attending the on-site meeting should bring original relevant documents to the scene.
The on-site shareholders’ meeting is expected to last half a day, and the meeting expenses will be borne by yourself.
Announcement is hereby made.
Shaanxi Kanghui Pharmaceutical Co., Ltd. Board of Directors
August 22, 2026
Attachment 1: Power of attorney
Reporting documents
Board resolution proposing to convene this shareholders’ meeting
Attachment 1: Power of attorney
Power of attorney
Shaanxi Kanghui Pharmaceutical Co., Ltd.:
I hereby authorize Mr. (Ms.) to represent the company (or myself) at the fifth extraordinary shareholders meeting of your company in 2026 to be held on September 7, 2026, and to exercise voting rights on my behalf. Number of common shares held by the client:
Number of preferred shares held by the client:
Client shareholder account number:
Serial number Name of non-cumulative voting motion Agree Oppose Abstain on the transfer of 51% shares of Chunsheng Pharmaceutical and related transactions
motion
Regarding the transfer of the equity of Chunsheng Pharmaceutical to passively form related guarantees
and accept proposals from related parties to provide counter-guarantees.
Proposal on increasing registered capital and amending the Articles of Association
case
Signature (stamped) of the principal: Signature of the trustee:
Trustee’s ID number: Trustee’s ID number:
Date of entrustment: Year Month Day Remarks:
The client should choose one of the "agree", "objection" or "abstain" intentions in the power of attorney and tick "√". If the client does not give specific instructions in this power of attorney, the trustee has the right to vote according to his own wishes.